Psychiatry and Clinical Psychopharmacology

A Multi-Dimensional Psychiatric Perspective on the Impact of the COVID-19 Pandemic


Department of Psychiatry, İstanbul University- Cerrahpaşa School of Medicine, Istanbul, Turkey


Department of Psychiatry, University of Alberta, Canada

Psychiatry and Clinical Psychopharmacology 2021; 31: 219-225
DOI: 10.5152/pcp.2021.21222
Read: 432 Downloads: 98 Published: 11 June 2021

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) arose in Wuhan, China in December 2019 and spread worldwide rapidly, and was declared a global pandemic by the World Health Organization as of March 2020. As the SARS-CoV-2 pandemic has spread worldwide, its impact is increasingly being recognized among vulnerable groups and also by the public in general. Recent findings indicate that patients with mental health disorders are among the groups most vulnerable to psychological stress and social hardships related to the current pandemic. Studies also indicate an increased risk of infection by SARS-CoV-2 in subjects with psychiatric disorders. Patients affected by SARS-CoV-2 may present to the psychiatrist with delirium, psychotic symptoms, depression, anxiety, post-traumatic stress disorder, and insomnia. Some patients will develop persistent somatic symptoms such as fatigue after the acute infection. In this article, we summarize the preliminary findings related to the effects of the SARSCoV- 2 pandemic on patients with mental health disorders, as well as recent research on psychiatric presentations in patients affected by SARS-CoV-2.

Cite this article as: Aksoy Poyraz C, Faruk Demirel Ö, Çağrı Poyraz B, M. Dursun S. A multi-dimensional psychiatric perspective on the impact of the COVID-19 pandemic. Psychiatr Clin Psychopharmacol. 2021; 31(2): 219-225.

EISSN 2475-0581